Form 4 for CRDF Cardiff Oncology, Inc.
Accepted 2024-12-16 00:00:00 ET · period of report 2024-12-12 · accession 0000950170-24-136725 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-16 | 2024-12-12 | CRDF | TANNENBAUM RENEE P | Dir | P - Purchase | $3.42 | +10.0K | 20.0K | +100% | +$34.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-12 | P | A | 10,000 | $3.42 | 20,000 | D | — | — |